Clinical trials
Phase 2 Lung Injury trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2010 | 1 |
| 2020 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 1 |
| Kinevant Sciences GmbH | 1 |
| University of Michigan Rogel Cancer Center | 1 |
| University of Tennessee | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Injury | 4 |
| Acute Lung Injury | 2 |
| COVID-19 | 2 |
| Respiratory Distress Syndrome | 2 |
| Bronchiolitis Obliterans | 1 |
| Coronavirus Infections | 1 |
| Cytokine Release Syndrome | 1 |
| Inflammation | 1 |
| Pneumonia | 1 |
| Respiratory Insufficiency | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.